Clene Inc. Warrant

YTD

ALL

Why Robinhood?

You can watch CLNNW and buy or sell other stocks, ETFs, and their options commission-free!

About CLNNW

Clene, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology therapeutics. It offers a nanotechnology drug platform for the development of a new class of orally administered neurotherapeutic drugs.

CEO

Robert Dee Etherington, MBA

CEORobert Dee Etherington, MBA

Employees

—

Employees—

Headquarters

Salt Lake City, Utah

HeadquartersSalt Lake City, Utah

Founded

2013

Founded2013

Employees

—

Employees—

CLNNW Key Statistics

Market cap

—

Market cap—

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

4.95K

Average volume4.95K

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$0.079

52 Week high$0.079

52 Week low

$0.022

52 Week low$0.022